港股异动 | 复宏汉霖(02696)早盘涨近12% 汉斯状®获英国NICE推荐正式纳入NHS报销体系

智通财经07-02

智通财经APP获悉，复宏汉霖(02696)早盘涨近12%，截至发稿，涨7.07%，报68.95港元，成交额5273.15万港元。消息面上，据复宏汉霖官微消息，Accord Healthcare英国(简称“Accord”)与公司近日宣布，H药汉斯状®(斯鲁利单抗，欧洲商品名：Hetronifly®)已获英国国家卫生与临床优化研究所(NICE)推荐正式纳入英格兰和威尔士国家医疗服务体系(NHS)常规...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2648756745?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-02 11:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648756745","market":"us","top_or_hot":-1,"title":"港股异动 | 复宏汉霖(02696)早盘涨近12% 汉斯状®获英国NICE推荐正式纳入NHS报销体系","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，复宏汉霖(02696)早盘涨近12%，截至发稿，涨7.07%，报68.95港元，成交额5273.15万港元。消息面上，据复宏汉霖官微消息，Accord Healthcare英国(简称“Accord”)与公司近日宣布，H药 汉斯状®(斯鲁利单抗，欧洲商品名：Hetronifly®)已获英国国家卫生与临床优化研究所(NICE)推荐正式纳入英格兰和威尔士国家医疗服务体系(NHS)常规...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1462167.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 复宏汉霖(02696)早盘涨近12% 汉斯状®获英国NICE推荐正式纳入NHS报销体系</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 复宏汉霖(02696)早盘涨近12% 汉斯状®获英国NICE推荐正式纳入NHS报销体系\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-02 11:12 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1462167.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，复宏汉霖(02696)早盘涨近12%，截至发稿，涨7.07%，报68.95港元，成交额5273.15万港元。消息面上，据复宏汉霖官微消息，Accord Healthcare英国(简称“Accord”)与公司近日宣布，H药 汉斯状®(斯鲁利单抗，欧洲商品名：Hetronifly®)已获英国国家卫生与临床优化研究所(NICE)推荐正式纳入英格兰和威尔士国家医疗服务体系(NHS)常规...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1462167.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4543","symbol_name":"AI","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1462167.html","article_id":"2648756745","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2648756745","pubTimestamp":1782961934,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，复宏汉霖早盘涨近12%，截至发稿，涨7.07%，报68.95港元，成交额5273.15万港元。消息面上，据复宏汉霖官微消息，Accord Healthcare英国与公司近日宣布，H药 汉斯状已获英国国家卫生与临床优化研究所推荐正式纳入英格兰和威尔士国家医疗服务体系常规临床使用范围。随着NICE推荐正式落地及NHS挂网的完成，H药成为首个获得NICE批准、可在英格兰和威尔士用于ES-SCLC治疗的抗PD-1单抗。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4543":"AI","NICE":"NICE系统","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","BK4566":"资本集团","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","02696":"复宏汉霖","BK4588":"碎股","VXUS":"国际股票ETF-Vanguard","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","BK1161":"生物科技","BK4585":"ETF&股票定投概念","BK4023":"应用软件","IE00BFMHRM44.USD":"NEUBERGER BERMAN GLOBAL EQUITY MEGATRENDS \"A\" (USD) ACC","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC"},"translate_title":"Hong Kong stock changes | Henlius (02696) rose nearly 12% in early trading Hans shape ® Recommended by UK NICE and formally incorporated into NHS reimbursement system","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NICE":1.5,"VXUS":1.5,"02696":1.5},"content_text":"智通财经APP获悉，复宏汉霖(02696)早盘涨近12%，截至发稿，涨7.07%，报68.95港元，成交额5273.15万港元。消息面上，据复宏汉霖官微消息，Accord Healthcare英国(简称“Accord”)与公司近日宣布，H药 汉斯状®(斯鲁利单抗，欧洲商品名：Hetronifly®)已获英国国家卫生与临床优化研究所(NICE)推荐正式纳入英格兰和威尔士国家医疗服务体系(NHS)常规临床使用范围。随着NICE推荐正式落地及NHS挂网的完成，H药成为首个获得NICE批准、可在英格兰和威尔士用于ES-SCLC治疗的抗PD-1单抗。斯鲁利单抗是一种免疫治疗药物，通过帮助人体自身免疫系统识别并攻击癌细胞发挥作用。该药物此前已获得英国药品和医疗保健产品监管局(MHRA)批准，成为英国首个获批用于ES-SCLC治疗的抗PD-1单抗。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"2","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2648756745","isCrawlerRequest":true}